Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lymphocyte-Activation Gene-3 Expression and Prognostic Value in Neoadjuvant-Treated Triple-Negative Breast Cancer

1 Jan 2018

Abstract excerpt

PURPOSE: In this study, we aimed to evaluate lymphocyte-activation gene-3 (LAG-3) expression and its prognostic value in neoadjuvant-treated triple-negative breast cancer (TNBC). METHODS: tumor-infiltrating lymphocyte (TILs) levels were examined using immunohistochemistry in 148 preand 114 post-neoadjuvant chemotherapy (NACT) specimens of human TNBC tissue. Correlations between expression levels and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Immune cells in cancer

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29963107
DOI: 10.4048/jbc.2018.21.2.124

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lymphocyte-Activation Gene-3 Expression and Prognostic Value in Neoadjuvant-Treated Triple-Negative Breast CancerPMID 29963107Read ↗

An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers.Semantic proximity Read ↗

Prognostic Impact of LAG-3 Expression in Early Breast CancerSemantic proximity Read ↗

Stromal Tumor-Infiltrating Lymphocytes Are Associated with Immune Checkpoint Protein Expression in Triple-Negative Breast Cancer Patients: A Subset of the Karachi PopulationSemantic proximity Read ↗

Molecular and Clinical Characterization of LAG3 in Breast Cancer Through 2994 SamplesSemantic proximity Read ↗

Lymphocyte-activation gene 3 in cancer immunotherapy: function, prognostic biomarker and therapeutic potentialsSemantic proximity Read ↗

Gene of the month: lymphocyte-activation gene 3 (LAG-3)Semantic proximity Read ↗

Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysisSemantic proximity Read ↗

Triple-Negative Breast Cancer: Intact Mismatch Repair and Partial Co-Expression of PD-L1 and LAG-3Semantic proximity Read ↗

High expression of TLR3 in triple-negative breast cancer predicts better prognosis —data from the Fudan University Shanghai Cancer Center cohort and tissue microarraysSemantic proximity Read ↗

CD8-positive T cells are key immune cells for predicting the therapeutic effect of neoadjuvant chemotherapy in triple-negative breast cancerSemantic proximity Read ↗

Understanding LAG-3 SignalingSemantic proximity Read ↗

Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.